Marc Ditmarsch

机构：Enceladus Pharmaceuticals (Netherlands) · ORCID：0000-0002-2970-1893

发表论文 88 篇 · 总被引 1106 次 · h-index 15

代表论文

Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients (2025 · Journal of the American College of Cardiology · 被引 35)
Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease (2025 · The Journal of Prevention of Alzheimer s Disease · 被引 11)
Efficacy of obicetrapib across the spectrum of background lipid-lowering therapies: pooled analyses of the BROADWAY and BROOKLYN randomized trials (2025 · European Journal of Preventive Cardiology · 被引 3)
Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background (2026 · Journal of Lipid Research · 被引 2)
Abstract 4368890: Cholesteryl Ester Transfer Protein (CETP) Inhibition with Obicetrapib Produces Substantial Reductions in LDL Particles: Pooled Analysis of BROOKLYN and BROADWAY Phase 3 Clinical Trials (2025 · Circulation · 被引 1)
SAFETY AND EFFICACY OF OBICETRAPIB IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (2025 · American Journal of Preventive Cardiology · 被引 1)